Professor Doctor Tomasz Banasiewicz from Poznan University of Medical Sciences, Poland, presented this topic at the "Application of Advanced Technology in Wound Management" workshop on 2/4. The event was co-organized by Bach Mai Hospital and EUPC Group.

Professor Banasiewicz emphasized that the goal of multi-technology application extends beyond mere skin closure; it also facilitates the recovery of underlying tissues. Therefore, doctors should move beyond single dressings or procedures, developing multi-modal strategies that shift from "dressing and waiting for healing" to active, comprehensive, and personalized recovery.

Professor Tomasz Banasiewicz shared about "Modern strategies in complex wound management: Autologous therapy, active biological dressings, and individualized multi-modal treatment". Photo: EUPC Group

Negative pressure wound therapy (npwt) stands out as a key technology. Initially understood simply as fluid drainage, npwt is now recognized as a comprehensive treatment system. It controls exudate, increases blood flow, promotes granulation tissue, reduces bacteria, and helps wounds contract. Npwt is particularly useful in abdominal and orthopedic surgeries, offering both treatment and complication prevention.

Professor Banasiewicz stressed that npwt is only effective when integrated into a comprehensive care strategy. This strategy includes: nutritional preparation, blood sugar control, weight reduction, smoking cessation, early mobilization, respiratory rehabilitation, and post-operative monitoring.

Another key highlight of the workshop was Plasma Complex technology, a regenerative solution introduced by the European Pharmaceutical and Cosmetics Group (EUPC Group) in collaboration with Doctor Robert Kasperek, a lecturer at Krakow School of Health Sciences. This technology is currently exclusively transferred to Vietnam. Plasma Complex utilizes prf (platelet-rich fibrin) derived from autologous blood, which is rich in growth factors to support wound healing and tissue regeneration. A distinguishing feature is its ability to release growth factors slowly and over an extended period, promoting stable recovery. Additionally, Plasma Complex shows potential in internal medicine aesthetics for skin improvement and rejuvenation.

Doctor Robert Kasperek shared about the application of platelet-rich plasma in orthopedics, such as treating joint diseases and its use in difficult-to-heal wounds. Photo: EUPC Group

Beyond large wound care and recovery technologies, the workshop also addressed and discussed managing infected wounds, comprehensive care for infected wounds with the role of nurses, and the early recognition and treatment of diabetic foot complications.

Doctor Robert Kasperek also presented autologous therapies such as platelet-rich plasma (prp) and platelet-rich fibrin (prf). These methods are applied in orthopedics for conditions like joint issues, ligament injuries, cartilage damage, delayed bone healing, and musculoskeletal pain. Prp and prf are also noted for supporting certain difficult-to-heal wounds by stimulating tissue regeneration and reducing inflammation. Their application on pressure ulcers, burns, diabetic foot wounds, and chronic wounds has shown significantly shortened recovery times.

From left to right: Doctor Robert Kasperek, Professor Tomasz Banasiewicz, Ms. Van Thi Ngoc Hai, during discussions with Bach Mai Hospital on 4/3. Photo: EUPC Group

During the workshop, experts and representatives from Bach Mai Hospital also discussed opportunities for cooperation in training, treatment, technology transfer, and research. The Polish expert also provided direct instruction on a clinical case at the hospital immediately after the event.

Ms. Van Thi Ngoc Hai, President of EUPC Group, the co-organizer of the workshop, stated the group's commitment to a long-term partnership in training and clinical application. EUPC Group aims to be a bridge, bringing advanced medical technology from Europe to Vietnam. She emphasized that regenerative medicine and internal medicine aesthetics are entering a breakthrough phase, and EUPC Group seeks to contribute to building a strong academic foundation for this development.

Van Ha